腫瘍溶解性ウイルス免疫療法の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Oncolytic Virus Immunotherapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00764 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、腫瘍溶解性ウイルス免疫療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍溶解性ウイルス免疫療法の種類別市場規模（腫瘍溶解性ウイルス光学、野生型腫瘍溶解性ウイルス）、用途別市場規模（病院、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Oncorus、Amgen、TILT Biotherapeutics、Shanghai Sunway Biotech、Sorrento Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・腫瘍溶解性ウイルス免疫療法の北米市場（アメリカ、カナダ、メキシコ） ・腫瘍溶解性ウイルス免疫療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍溶解性ウイルス免疫療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍溶解性ウイルス免疫療法の南米市場（ブラジル、アルゼンチン） ・腫瘍溶解性ウイルス免疫療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腫瘍溶解性ウイルス光学、野生型腫瘍溶解性ウイルス ・用途別分析：病院、クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Oncolytic Virus Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Oncolytic Virus Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Oncolytic Virus Immunotherapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oncolytic Virus Immunotherapy market has been segmented into:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses

By Application, Oncolytic Virus Immunotherapy has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus Immunotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus Immunotherapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus Immunotherapy market.

The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus Immunotherapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Oncolytic Virus Immunotherapy Market Share Analysis
Oncolytic Virus Immunotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus Immunotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus Immunotherapy sales, revenue and market share for each player covered in this report.

The major players covered in Oncolytic Virus Immunotherapy are:
Merck
Oncorus
Amgen
TILT Biotherapeutics
Shanghai Sunway Biotech
Sorrento Therapeutics

レポート目次

---

Table of Contents

1 Oncolytic Virus Immunotherapy Market Overview
1.1 Product Overview and Scope of Oncolytic Virus Immunotherapy
1.2 Classification of Oncolytic Virus Immunotherapy by Type
1.2.1 Global Oncolytic Virus Immunotherapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Type in 2019
1.2.3 Engineering Oncolytic Viruses
1.2.4 Wild-Type Oncolytic Viruses
1.3 Global Oncolytic Virus Immunotherapy Market by Application
1.3.1 Overview: Global Oncolytic Virus Immunotherapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Oncolytic Virus Immunotherapy Market by Regions
1.4.1 Global Oncolytic Virus Immunotherapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oncolytic Virus Immunotherapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Immunotherapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Immunotherapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Immunotherapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Immunotherapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Immunotherapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Oncorus
2.2.1 Oncorus Details
2.2.2 Oncorus Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Oncorus SWOT Analysis
2.2.4 Oncorus Product and Services
2.2.5 Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 TILT Biotherapeutics
2.4.1 TILT Biotherapeutics Details
2.4.2 TILT Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 TILT Biotherapeutics SWOT Analysis
2.4.4 TILT Biotherapeutics Product and Services
2.4.5 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shanghai Sunway Biotech
2.5.1 Shanghai Sunway Biotech Details
2.5.2 Shanghai Sunway Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shanghai Sunway Biotech SWOT Analysis
2.5.4 Shanghai Sunway Biotech Product and Services
2.5.5 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sorrento Therapeutics
2.6.1 Sorrento Therapeutics Details
2.6.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sorrento Therapeutics SWOT Analysis
2.6.4 Sorrento Therapeutics Product and Services
2.6.5 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oncolytic Virus Immunotherapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncolytic Virus Immunotherapy Players Market Share
3.2.2 Top 10 Oncolytic Virus Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Regions
4.2 North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.3 Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
5 North America Oncolytic Virus Immunotherapy Revenue by Countries
5.1 North America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
5.2 USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
5.3 Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
6 Europe Oncolytic Virus Immunotherapy Revenue by Countries
6.1 Europe Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
6.2 Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
6.3 UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
6.4 France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
6.5 Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
6.6 Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries
7.1 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
7.2 China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
7.3 Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
7.4 Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
7.5 India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
8 South America Oncolytic Virus Immunotherapy Revenue by Countries
8.1 South America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
8.2 Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oncolytic Virus Immunotherapy by Countries
9.1 Middle East & Africa Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
9.3 UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global Oncolytic Virus Immunotherapy Market Forecast by Type (2019-2024)
10.3 Engineering Oncolytic Viruses Revenue Growth Rate (2015-2025)
10.4 Wild-Type Oncolytic Viruses Revenue Growth Rate (2015-2025)
11 Global Oncolytic Virus Immunotherapy Market Segment by Application
11.1 Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2015-2020)
11.2 Oncolytic Virus Immunotherapy Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Oncolytic Virus Immunotherapy Market Size Forecast (2021-2025)
12.1 Global Oncolytic Virus Immunotherapy Market Size Forecast (2021-2025)
12.2 Global Oncolytic Virus Immunotherapy Market Forecast by Regions (2021-2025)
12.3 North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
12.4 Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
12.6 South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Oncolytic Virus Immunotherapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncolytic Virus Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncolytic Virus Immunotherapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oncolytic Virus Immunotherapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Oncolytic Virus Immunotherapy Major Business
Table 7. Merck Oncolytic Virus Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Oncolytic Virus Immunotherapy Product and Solutions
Table 10. Merck Oncolytic Virus Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Oncorus Corporate Information, Location and Competitors
Table 12. Oncorus Oncolytic Virus Immunotherapy Major Business
Table 13. Oncorus Oncolytic Virus Immunotherapy Total Revenue (USD Million) (2018-2019)
Table 14. Oncorus SWOT Analysis
Table 15. Oncorus Oncolytic Virus Immunotherapy Product and Solutions
Table 16. Oncorus Oncolytic Virus Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amgen Corporate Information, Location and Competitors
Table 18. Amgen Oncolytic Virus Immunotherapy Major Business
Table 19. Amgen Oncolytic Virus Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 20. Amgen SWOT Analysis
Table 21. Amgen Oncolytic Virus Immunotherapy Product and Solutions
Table 22. Amgen Oncolytic Virus Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. TILT Biotherapeutics Corporate Information, Location and Competitors
Table 24. TILT Biotherapeutics Oncolytic Virus Immunotherapy Major Business
Table 25. TILT Biotherapeutics Oncolytic Virus Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 26. TILT Biotherapeutics SWOT Analysis
Table 27. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product and Solutions
Table 28. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Shanghai Sunway Biotech Corporate Information, Location and Competitors
Table 30. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Major Business
Table 31. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 32. Shanghai Sunway Biotech SWOT Analysis
Table 33. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product and Solutions
Table 34. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sorrento Therapeutics Corporate Information, Location and Competitors
Table 36. Sorrento Therapeutics Oncolytic Virus Immunotherapy Major Business
Table 37. Sorrento Therapeutics Oncolytic Virus Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 38. Sorrento Therapeutics SWOT Analysis
Table 39. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product and Solutions
Table 40. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Players (2015-2020)
Table 42. Global Oncolytic Virus Immunotherapy Revenue Share by Players (2015-2020)
Table 43. Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2015-2020)
Table 45. North America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table 46. North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 47. Europe Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table 50. South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 53. Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Type (2015-2020)
Table 54. Global Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Table 55. Global Oncolytic Virus Immunotherapy Revenue Forecast by Type (2021-2025)
Table 56. Global Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table 57. Global Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Table 58. Global Oncolytic Virus Immunotherapy Revenue Forecast by Application (2021-2025)
Table 59. Global Oncolytic Virus Immunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oncolytic Virus Immunotherapy Picture
Figure 2. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type in 2019
Figure 3. Engineering Oncolytic Viruses Picture
Figure 4. Wild-Type Oncolytic Viruses Picture
Figure 5. Oncolytic Virus Immunotherapy Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Global Oncolytic Virus Immunotherapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Oncolytic Virus Immunotherapy Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Oncolytic Virus Immunotherapy Revenue Market Share in 2019
Figure 18. Global Top 10 Players Oncolytic Virus Immunotherapy Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2015-2020)
Figure 22. Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions in 2018
Figure 23. North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 24. Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 26. South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 28. North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 29. North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure 30. USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 31. Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 33. Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure 35. Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 36. UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 37. France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 38. Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 39. Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure 42. China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 43. Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 44. Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 45. India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 47. South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 48. South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure 49. Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 54. UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 57. Global Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Figure 58. Global Oncolytic Virus Immunotherapy Revenue Share by Type in 2019
Figure 59. Global Oncolytic Virus Immunotherapy Market Share Forecast by Type (2021-2025)
Figure 60. Global Engineering Oncolytic Viruses Revenue Growth Rate (2015-2020)
Figure 61. Global Wild-Type Oncolytic Viruses Revenue Growth Rate (2015-2020)
Figure 62. Global Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure 63. Global Oncolytic Virus Immunotherapy Revenue Share by Application in 2019
Figure 64. Global Oncolytic Virus Immunotherapy Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Oncolytic Virus Immunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
Figure 72. Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
Figure 74. South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---